Dr. Peter P. Rullan, MD

Dr. Rullan practices at Alfa Surgery Center, LLC in Chula Vista, California.

Dr. Rullan's NPI, 1114963170, was assigned on June 20, 2006. Dr. Rullan graduated from University of Puerto Rico, Medical Sciences Campus in 1979. Dr. Rullan holds California license G42243.

Dr. Rullan's primary practice is Alfa Surgery Center, LLC, at 256 Landis Ave, Chula Vista, CA 91910 in San Diego County. The practice phone is (619) 990-1698.

Dr. Rullan's primary practice is Alfa Surgery Center, LLC in Chula Vista, California. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Rullan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rullan practices, 2 sites in all. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Rullan's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. Rullan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rullan's licenses on file in 2 states: California and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Rullan treats.

CMS data shows 6,151 Medicare services from Dr. Rullan across 34 procedure codes in 2024, for 673 Medicare patients. Medicare paid $364,817 for them. Every service was in an office.

CMS counts 673 Medicare patients who saw Dr. Rullan in 2024. The largest group is 75 to 84, with 271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rullan's median patient age at 72, with 55% women.

In 2024, Dr. Rullan wrote 141 Medicare Part D claims for 56 patients. 91% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $302 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Rullan for performance year 2024, reported individually. Dr. Rullan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,510 procedures of removal of skin lesions by Dr. Rullan, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Rullan, published from 2013 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Chemexfoliation, Skin Aging and Croton Oil. Dr. Rullan has published most often in Dermatol Surg. Dr. Rullan's most frequent co-authors are Seaver Lee Soon, MD, Jennifer M. Rullan, MD and Vera B. Morhenn, MD.

Dmand AI links Dr. Rullan to 1 clinical trial.

CMS Open Payments shows 524 general payments to Dr. Rullan from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Allergan Inc. paid the most, $2,636.

Dmand AI lists 2 awards for Dr. Rullan.

Dr. Rullan graduated from University of Puerto Rico, Medical Sciences Campus in 1979. Dr. Rullan is a member of AAD and ASDS.

Dr. Rullan is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.